ONC Share Price

Open 0.63 Change Price %
High 0.64 1 Day 0.00 0.00
Low 0.61 1 Week -0.23 -27.06
Close 0.62 1 Month -0.25 -28.74
Volume 373617 1 Year 0.07 12.73
52 Week High 1.13
52 Week Low 0.19
ONC Important Levels
Resistance 2 0.65
Resistance 1 0.64
Pivot 0.62
Support 1 0.60
Support 2 0.59
TSE Canada Most Active Stocks
BIN 41.40 -1.62%
BIN 41.40 -1.62%
LSG 2.08 8.33%
LSG 2.08 8.33%
LSG 2.08 8.33%
TBE 0.03 0.00%
BBD-B 2.25 3.21%
ECA 14.46 0.91%
ECA 14.46 0.91%
ECA 14.46 0.91%
More..
TSE Canada Top Gainers Stocks
TVI 0.02 100.00%
CUR 0.02 100.00%
CUR 0.02 100.00%
CUR 0.02 100.00%
PWC 0.10 25.00%
PWC 0.10 25.00%
BLU 0.40 21.21%
CUM 0.90 13.92%
CUM 0.90 13.92%
BU 1.66 12.93%
More..
TSE Canada Top Losers Stocks
TPL 0.02 -33.33%
TPL 0.02 -33.33%
GBV 0.46 -24.59%
CTU-A 0.19 -9.52%
RN 0.11 -8.33%
RN 0.11 -8.33%
KOR 0.80 -8.05%
KOR 0.80 -8.05%
RKN 0.82 -7.87%
RKN 0.82 -7.87%
More..

Oncolytics Biotech Inc (TSE: ONC)

ONC Technical Analysis 2
As on 26th May 2017 ONC Share Price closed @ 0.62 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.44 & Strong Sell for SHORT-TERM with Stoploss of 0.76 we also expect STOCK to react on Following IMPORTANT LEVELS.
ONC Target for May
1st Target up-side 1.05
2nd Target up-side 1.23
3rd Target up-side 1.41
1st Target down-side 0.53
2nd Target down-side 0.35
3rd Target down-side 0.17
ONC Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.oncolyticsbiotech.com
ONC Address
ONC
1167 Kensington Crescent NW
Suite 210
Calgary, AB T2N 1X7
Canada
Phone: 403-670-7377
Fax: 403-283-0858
ONC Latest News
Oncolytics Biotech Prices Public Offering of Units   MarketWatch   - 24th May 17
IIROC Trade Resumption - Oncolytics Biotech Inc.   Stockhouse   - 24th May 17
Oncolytics Biotech® Announces Proposed Public Offering   Canada NewsWire (press release)   - 24th May 17
Oncolytics Biotech® Inc. Announces FDA Fast Track Designation for REOLYSIN® in ...   Canada NewsWire (press release)   - 08th May 17
Oncolytics Biotech® Inc. Announces 2017 First Quarter Results   Canada NewsWire (press release)   - 05th May 17
Finally, Some Good News For Oncolytics   Seeking Alpha   - 03rd Apr 17
Oncolytics Biotech® Inc. Reports Additional Data from Randomized Phase II ...   PR Newswire (press release)   - 10th Aug 16
Where Can Oncolytics Go After Dismal ASCO Results?   Seeking Alpha   - 20th May 16
BRIEF-Oncolytics Biotech to offer shares in public offering   Reuters   - 10th May 16
Oncolytics Biotech, Inc.: An Intro To These Next Few Crucial Weeks   Seeking Alpha   - 12th Feb 13
Interactive Technical Analysis Chart Oncolytics Biotech Inc ( ONC TSE Canada )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Oncolytics Biotech Inc
ONC Business Profile
Oncolytics Biotech Inc., a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancers. The company develops REOLYSIN, a therapeutic reovirus that is in various clinical trials for use as human cancer therapeutic. Its cancer product is a potential therapeutic for tumours possessing an activated Ras pathway. The company was founded in 1998 and is headquartered in Calgary, Canada.